-
MIDD approaches can advance the understanding of pharmacological activity, efficacy and safety Provide support in the development and application of state-of-the-art quantitative methodologies
-
MIDD approaches can advance the understanding of pharmacological activity, efficacy and safety Provide support in the development and application of state-of-the-art quantitative methodologies
-
other groups to share learnings and enhance consistency in best practices across sites, disease areas, and interventional modalities Keep up to date with emerging literature in the area of mechanistic
-
literature in the area of mechanistic modeling and simulation sciences Continue to build a personal track record of publication in the area of PKPD modeling and simulation and contribute to PDM's external
-
Remain current in the scientific literature and state of the art techniques. Qualifications Must-Have Candidate should have a PhD in virology and/or immunology with at least 6+ years of relevant experience
-
for regulatory submissions. Knowledge of experimental design. Strong understanding of the state-of-the-art technologies to evaluate and leverage them for improved business processes. Aptitude to identify